Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

Inclusion Criteria: * Non-smoking males and females, = 18 and = 80 years with a BMI of = 37 kg/m2 * Type 1 or type 2 diabetic * Subjects with mild or moderate DNP and subjects with normal renal function, based on GFR rate and albuminuria * Normal pulmonary function and performance based on PFTs Exclusion Criteria: * No history of COPD, asthma, or active respiratory infection; must be able to perform PFTs * No dose and/or formulation changes within the preceding 6 weeks for any concomitant medications * No clinically significant major organ/systemic disease * No previous or current chemotherapy or radiation therapy that may result in pulmonary toxicity * No clinically significant abnormalities on screening laboratory evaluation, except abnormal laboratory renal parameters in subjects with DNP